Table 1 Reported benefits of MDT meetings in relation to health profession, hospital type, discipline and cancer type being discussed
From: Benefits, barriers and opinions on multidisciplinary team meetings: a survey in Swedish cancer care
| Â | Frequency of all responses | Nurses/ coordinators | Physicians | P-value | University hospital | County hospital | P-value | Pathology | Radiology | Medicine | Surgery | P-value | Breast cancer | Lung cancer | GI cancer | Uro/Gyn cancer | Other tumors | P-value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compiled clinical information and review grants accurate treatment recommendations | 81% | 75% | 83% | 0.221 | 78% | 84% | 0.381 | 100% | 86% | 78% | 81% | 0.278 | 76% | 77% | 88% | 74% | 96% | 0.120 |
Multidisciplinary evaluation | 67% | 70% | 66% | 0.732 | 59% | 75% | 0.026 | 57% | 68% | 69% | 67% | 0.880 | 63% | 63% | 71% | 64% | 74% | 0.830 |
Promotes adherence to clinical guidelines | 34% | 30% | 35% | 0.512 | 36% | 32% | 0.550 | 29% | 46% | 29% | 33% | 0.449 | 35% | 29% | 36% | 31% | 39% | 0.897 |
Increases team competence | 26% | 26% | 26% | 1.000 | 34% | 19% | 0.015 | 14% | 21% | 27% | 27% | 0.702 | 22% | 37% | 21% | 33% | 22% | 0.327 |
Increases patient safety | 22% | 19% | 23% | 0.699 | 24% | 20% | 0.628 | 29% | 25% | 13% | 25% | 0.274 | 24% | 26% | 19% | 21% | 17% | 0.924 |
Strengthens teamwork | 12% | 11% | 12% | 1.000 | 13% | 10% | 0.535 | 43% | 7% | 9% | 11% | 0.005 | 13% | 11% | 14% | 13% | 4% | 0.833 |
Training opportunity for junior colleagues | 8% | 2% | 10% | 0.073 | 5% | 10% | 0.194 | 0% | 0% | 15% | 8% | 0.075 | 4% | 11% | 7% | 10% | 9% | 0.781 |
Shortens time from diagnosis to treatment | 14% | 28% | 9% | < 0.001* | 18% | 11% | 0.240 | 14% | 21% | 9% | 14% | 0.504 | 13% | 14% | 14% | 18% | 13% | 0.973 |
Grants equal care | 13% | 17% | 12% | 0.474 | 13% | 13% | 1.000 | 7% | 7% | 18% | 14% | 0.494 | 17% | 20% | 10% | 13% | 4% | 0.401 |
Facilitates patient referral between clinics | 7% | 11% | 6% | 0.212 | 4% | 10% | 0.096 | 0% | 4% | 11% | 8% | 0.442 | 15% | 3% | 5% | 8% | 0% | 0.095 |
Strengthens regional collaboration | 4% | 0% | 5% | 0.116 | 3% | 5% | 0.719 | 0% | 0% | 9% | 3% | 0.100 | 2% | 6% | 2% | 3% | 13% | 0.138 |
Identification of patients suitable for clinical trials | 3% | 6% | 1% | 0.121 | 0% | 5% | 0.050 | 7% | 0% | 2% | 3% | 0.559 | 2% | 0% | 3% | 5% | 0% | 0.649 |
Attention to patient preferences | 1% | 4% | 0% | 0.056 | 1% | 1% | 1.000 | 0% | 0% | 0% | 2% | 0.727 | 0% | 0% | 0% | 3% | 4% | 0.217 |